Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Test results

19 May 2009 08:00

RNS Number : 4559S
Plant Health Care PLC
19 May 2009
 



19 May 2009

Plant Health Care plc 

("Plant Health Care" or "the Company")

The Journal of the American Society of Horticultural Science recently published the findings of an extensive testing and research progamme carried out on Plant Health Care's harpin product when used with lettuce (J. AMER. SOC. HORT. SCI. 134(1):141-147. 2009.). 

A summary of the findings is set out below.


 

 

Researchers from three US academic institutions (Rutgers University, University of California, Davis and University of Arizona), led by Dr. Jorge M. Fonseca at the University of Arizona's Yuma Agricultural Center, have investigated the effect of a pre-harvest treatment of head lettuce with Plant Health Care's harpin protein which is known to boost plants' growth processes and resistance to disease.

Lettuce plants grown at the three locations were treated, five days before harvest with three different rates of the harpin A/B second generation protein. After processing and bagging the lettuces were cool-stored and their quality evaluated over a period of 20 days.

At the two higher rates, the harpin-treated lettuce from California consistently showed better visual quality and lower microbial population than the control. Similarly in Arizona, for part of the storage period, microbial population was lower and visual quality was higher in lettuce treated with harpin at the two higher rates. Overall results in New Jersey showed no major differences among treatments. 

In additional experiments it was shown that antioxidants increased by 40% in head leaves when plants were treated with the two higher rates of harpin, but no visible changes were observed in outer leaves. Furthermore, phenolic content was higher in all treated lettuce than in the control lettuce after 24 hours. Six days later, the levels fell back to the initial stage. 

Overall, it was shown that a pre-harvest, field application of harpin can improve quality of fresh-cut head lettuce under certain environmental conditions. The results with antioxidant activity and phenolic content suggest that improvement in quality is probably the result of alteration of metabolites' composition.

The study clearly shows the potential for harpin use as a pre-harvest treatment to improve several important health and appearance-related aspects of this important produce crop.

- ends -

Enquiries:

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Evolution Securities

Tavistock Communications 

Tim Worlledge / Tim Redfern

Jeremy Carey/Matt Ridsdale

Tel: +44-20-7071-4300 

Tel: +44-20-7920-3150

tim.worlledge@evosecuties.com

tim.redfern@evosecuties.com

jcarey@tavistock.co.uk

mridsdale@tavistock.co.uk

About Plant Health Care plc:

Plant Health Care plc is a leading provider of natural products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, Plant Health Care currently has approximately 90 employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands. The Company listed on the AIM market of the London Stock Exchange in July 2004. Ticker symbol is PHC.

Plant Health Care's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAKSPFLLNEFE
Date   Source Headline
29th Aug 200810:37 amRNSNotice of Results
15th Aug 200812:36 pmRNSHolding(s) in Company
1st Aug 20081:08 pmRNSTotal Voting Rights
7th Jul 200812:21 pmRNSHolding(s) in Company
4th Jul 20087:00 amRNSProduct Update
3rd Jul 20087:00 amRNSCleantech Index
2nd Jul 200812:07 pmRNSStock Award
1st Jul 200811:49 amRNSTotal Voting Rights
17th Jun 20085:36 pmRNSAdditional Listing
17th Jun 20083:47 pmRNSNotification of Shareholding
13th Jun 20082:07 pmRNSHolding(s) in Company
12th Jun 20087:00 amRNSField Trials
6th Jun 200812:59 pmRNSResult of Annual General Meet
6th Jun 20087:00 amRNSAGM Statement and Trading Upd
3rd Jun 20087:30 amRNSField Trials
2nd Jun 20089:50 amRNSTotal Voting Rights
13th May 200812:41 pmRNSDirectors' dealings and addit
1st May 20082:39 pmRNSAdditional Listing
30th Apr 20086:11 pmRNSAnnual Report and Accounts
30th Apr 200811:24 amRNSTotal Voting Rights
28th Apr 20088:09 amRNSNew Trials
14th Apr 20085:39 pmRNSDirector/PDMR Shareholding
2nd Apr 20086:18 pmRNSDirector/PDMR Shareholding
1st Apr 20087:01 amRNSTotal Voting Rights
1st Apr 20087:01 amRNSDirectorate Change
31st Mar 20087:02 amRNSFinal Results
12th Mar 20084:40 pmRNSAdditional Listing
29th Feb 20084:59 pmRNSTotal Voting Rights
21st Feb 20087:01 amRNSStatement re Monsanto
18th Feb 20088:00 amRNSASA Partnership
12th Feb 20085:14 pmRNSAdditional Listing
31st Jan 20084:03 pmRNSTotal Voting Rights
21st Jan 20087:01 amRNSRe Agreement
21st Jan 20087:01 amRNSProduct Update
21st Jan 20087:01 amRNSTrading Statement
14th Jan 200811:57 amRNSNotification of Shareholding
9th Jan 20089:00 amRNSField Trial Update
31st Dec 200712:51 pmRNSTotal Voting Rights
19th Dec 20079:00 amRNSNotification of Shareholding
3rd Dec 20073:00 pmRNSTotal Voting Rights
20th Nov 20079:15 amRNSAdditional Listing
1st Nov 200712:16 pmRNSTotal Voting Rights
24th Oct 20076:13 pmRNSStock Award
22nd Oct 200710:35 amRNSNotification of Shareholding
5th Oct 20073:56 pmRNSNotification of Shareholding
2nd Oct 20074:46 pmRNSNotification of Shareholding
2nd Oct 200712:59 pmRNSTotal Voting Rights
1st Oct 20075:54 pmRNSNotification of Shareholding
1st Oct 20075:51 pmRNSNotification of Shareholding
1st Oct 20073:22 pmRNSDoc re. Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.